Nicotinamide supplementation has been linked to improvements in neurodegenerative symptoms by addressing amyloid-beta and tau pathologies, neuroinflammation, and mitochondrial dysfunction, offering potential therapeutic benefits for conditions like Alzheimer’s disease.

Study reveals a correlation between key opinion leaders in oncology and higher industry payments, prompting calls for stronger regulations to address potential biases.

This phase 2 study underscores the challenges in enhancing therapeutic outcomes in metastatic castration-resistant prostate cancer with AZD4635 combined with immunotherapy, indicating a minimal PSA response among treated patients.

The AGS Beers Criteria highlights medications that pose significant risks to the elderly, such as growth hormones and certain antidepressants, guiding physicians towards safer prescribing practices.

In the wake of allegations against Dr. Oluwafemi Esho, the medical community reflects on the critical importance of ethical conduct in maintaining patient trust and professional credibility.

In cases of prostate cancer post-aquablation therapy, managing residual tissue and persistent PSA levels poses significant challenges for surgical intervention, as detailed by Dr. Edward M. Schaeffer.